IVAR E ROTH, DPM, MPH
Medical Practice in Newport Beach, CA
License number
California E2628A
Category
Medical Practice
Type
Foot & Ankle Surgery
Address
Address
351 Hospital Rd Suite #407, Newport Beach, CA 92663
Phone
(949) 650-1147
(949) 650-6434 (Fax)
(949) 650-6434 (Fax)
Personal information
See more information about IVAR E ROTH at radaris.comName
Address
Phone
29 Gleneagles Dr, Newport Beach, CA 92660
351 Hospital Rd #407, Newport Beach, CA 92663
3 Honors Dr, Newport Beach, CA 92660
512 Carnation Ave, Corona del Mar, CA 92625
Organization information
See more information about IVAR E ROTH at bizstanding.comIvar E. Roth
351 Hospital Rd #407, Newport Beach, CA 92663
Phone:
(949) 650-1147 (Phone), (949) 650-6434 (Fax)
Email:
SIC6:
806202 - Hospitals
Ivar E Roth Dpm Mph
351 Hospital Rd, Newport Beach, CA 92663
Industry:
Podiatric Surgeon
Doing business as:
Ivar E. Roth A Podiatric Corporation
Registration:
Jul 21, 1986
Phone:
(949) 650-1147 (Phone)
State ID:
01380841
Business type:
Articles of Incorporation
Podiatrist, President:
Ivar E. Roth (Podiatrist, President)
Professional information
Ivar E Roth, Newport Beach CA - DPM (Doctor of Podiatric Medicine)
Specialties:
Podiatric Surgery, Podiatric Foot & Ankle Surgery
Address:
Ivar E Roth DPM
351 Hospital Rd SUITE 407, Newport Beach 92663
(949) 650-1147 (Phone)
351 Hospital Rd SUITE 407, Newport Beach 92663
(949) 650-1147 (Phone)
Languages:
English
Hospitals:
Ivar E Roth DPM
351 Hospital Rd SUITE 407, Newport Beach 92663
Hoag Memorial Hospital Presbyterian
1 Hoag Dr, Newport Beach 92663
351 Hospital Rd SUITE 407, Newport Beach 92663
Hoag Memorial Hospital Presbyterian
1 Hoag Dr, Newport Beach 92663
Antifungal Products And Method Of Use
US Patent:
2005027, Dec 8, 2005
Filed:
Jun 4, 2004
Appl. No.:
10/861739
Inventors:
Ivar Roth - Newport Beach CA, US
International Classification:
A61K035/78
US Classification:
424742000, 424769000
Abstract:
A topical antifungal formulation and kit and a method of use includes the steps of combining an oil extract of melaleuca alternifolia and an oil extract of eucalyptus australiana in each of four formulations wherein, the first one of the four formulations is prepared by further combining ethanol, ethoxylated castor oil, and zinc phenosulphonate; the second one of the four formulations is prepared by further combining petrolatum, ethoxylated castor oil, jojoba oil, aloe vera and lanolin, glyceryl stearate, and octyl stearate and with or without Miconazole Nitrate 2% and/or any FDA topical antifungal drug product; the third one of the four formulations is prepared by further combining ethoxylated castor oil, at least one lauryl sulphate, coccabetaine, and coconut diethanolamine; and the fourth one of the four formulations is prepared by further combining Miconazole Nitrate 2% and/or any FDA topical antifungal drug product petrolatum, jojoba oil, aloe vera and lanolin.
Device For Foot Stabilization
US Patent:
2005025, Nov 10, 2005
Filed:
May 10, 2004
Appl. No.:
10/841928
Inventors:
Ivar Roth - Newport Beach CA, US
Assignee:
Dr. Roth's Footcare Products LLC - Newport Beach CA
International Classification:
A61F005/00, A43B013/38
US Classification:
602008000
Abstract:
A supportive device for the transverse metatarsal arch of the foot is comprised of a fabric-coated elasticized strap enclosing a specially designed pad of rubberized material. This strap is wrapped snugly around the transverse metatarsal arch with the enclosed pad strategically placed to provide optimum arch support, metatarsal relief and secured by a hook and loop type fastener strip.
Foot Fixer Kit
US Patent:
2003022, Dec 11, 2003
Filed:
Jun 6, 2003
Appl. No.:
10/250151
Inventors:
Ivar Roth - Newport Beach CA, US
International Classification:
A61K035/78, A61K031/315
US Classification:
424/731000, 424/742000, 424/744000, 424/757000, 424/769000, 514/494000
Abstract:
A topical antifungal, antimicrobial and antibacterial formulation and kit and a method of use includes the steps of combining an oil extract of melaleuca alternifolia and an oil extract of eucalyptus australiana in each of four formulations wherein, the first one of the four formulations is prepared by further combining ethanol, ethoxylated castor oil, and zinc phenosulphonate; the second one of the four formulations is prepared by further combining petrolatum, ethoxylated castor oil, jojoba oil, aloe vera and lanolin, glyceryl stearate, and octyl stearate; the third one of the four formulations is prepared by further combining ethoxylated castor oil, at least one lauryl sulphate, coccabetaine, and coconut diethanolamine; and the fourth one of the four formulations is prepared by further combining petrolatum, jojoba oil, aloe vera and lanolin.